ES2080486T3 - Sg(beta)-1,4-galactanasa y una secuencia de adn. - Google Patents

Sg(beta)-1,4-galactanasa y una secuencia de adn.

Info

Publication number
ES2080486T3
ES2080486T3 ES92904937T ES92904937T ES2080486T3 ES 2080486 T3 ES2080486 T3 ES 2080486T3 ES 92904937 T ES92904937 T ES 92904937T ES 92904937 T ES92904937 T ES 92904937T ES 2080486 T3 ES2080486 T3 ES 2080486T3
Authority
ES
Spain
Prior art keywords
galactanase
beta
dna sequence
obtainable
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904937T
Other languages
English (en)
Inventor
Kurt Dorreich
Henrik Dalboge
Jan Moller Mikkelsen
Marcel Mischler
Flemming Mark Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208762&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2080486(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2080486T3 publication Critical patent/ES2080486T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01089—Arabinogalactan endo-beta-1,4-galactanase (3.2.1.89)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA SECUENCIA AMINOACIDA PARCIAL DE UNA BETA-1,4-GALACTANASA MEDIANTE ASPERGILLUS ACULEATUS, Y TAMBIEN SECUENCIAS DE DNA RECOMBINANTE CORRESPONDIENTES, VECTORES Y HUESPEDES TRANSFORMADOS. SE DESCRIBE TAMBIEN EL USO DE LA BETA-1,4-GALACTANASA O UN PREPARACION DE PECTINASA ENRIQUECIDA CON LA BETA-1,4-GALACTANASA PARA LA DEGRADACION O LA MODIFICACION DE LA PAREDES DE CELULAS VEGETALES.
ES92904937T 1991-02-06 1992-02-06 Sg(beta)-1,4-galactanasa y una secuencia de adn. Expired - Lifetime ES2080486T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91610007A EP0498137A1 (en) 1991-02-06 1991-02-06 Novel expression systems

Publications (1)

Publication Number Publication Date
ES2080486T3 true ES2080486T3 (es) 1996-02-01

Family

ID=8208762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904937T Expired - Lifetime ES2080486T3 (es) 1991-02-06 1992-02-06 Sg(beta)-1,4-galactanasa y una secuencia de adn.

Country Status (12)

Country Link
US (1) US5474922A (es)
EP (2) EP0498137A1 (es)
JP (1) JP3240002B2 (es)
AT (1) ATE130630T1 (es)
AU (1) AU649789B2 (es)
CA (1) CA2100775A1 (es)
DE (1) DE69206258T2 (es)
DK (1) DK0571475T3 (es)
ES (1) ES2080486T3 (es)
GR (1) GR3018913T3 (es)
NZ (1) NZ241560A (es)
WO (1) WO1992013945A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0635574B1 (en) * 1993-07-23 2003-04-23 Dsm N.V. Selection marker gene free recombinant strains, a method for obtaining them and the use of these strains
GB9320930D0 (en) * 1993-10-12 1993-12-01 Zeneca Ltd Modified fruit
GB9403423D0 (en) * 1994-02-23 1994-04-13 Unilever Plc Novel exo-(1-4)- beta-D galactanase
US6030648A (en) * 1994-06-15 2000-02-29 Novo Nordisk A/S Extracts/cloud stability
EP0862371B1 (en) * 1995-11-06 2002-05-08 Novozymes A/S Use of galactanase in animal feed
JP4267696B2 (ja) * 1996-03-01 2009-05-27 ノボザイムス アクティーゼルスカブ ガラクタナーゼ活性を有する酵素
CN1212012A (zh) * 1996-03-01 1999-03-24 诺沃挪第克公司 具有半乳聚糖酶活性的酶
US6331426B1 (en) 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
CN112961852B (zh) * 2019-12-12 2023-11-21 青岛蔚蓝生物集团有限公司 一种启动子及其在棘孢曲霉基因自克隆表达中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302336A1 (fr) * 1975-02-26 1976-09-24 Baxter Laboratories Inc Procede pour la fabrication d'un melange d'enzymes
SE461659B (sv) * 1981-12-22 1990-03-12 Novo Industri As Foerfarande foer framstaellning av enzymet sps-as med foermaaga att soenderdela hoegmolekylaer kolhydrat
CA1198699A (en) * 1981-12-22 1985-12-31 Jens L. Adler-Nissen Agent for decomposition of vegetable remanence, especially soy remanence, a method for production of a purified vegetable protein product, and a purified vegetable protein product
US4483874A (en) * 1982-05-06 1984-11-20 Novo Industri A/S Preparation of milk substitute
DE3529221A1 (de) * 1985-08-20 1987-02-26 I Centar Biotechnologija Verfahren zur gewinnung eines pektolytischen enzympraeparats
FR2588886B1 (fr) * 1985-10-18 1988-06-24 Comite Eco Agric Prod Chanvre Procede de traitement biochimique de plantes fibreuses liberiennes ou cellulosiques et assimilees
JPH01296995A (ja) * 1988-05-21 1989-11-30 Osaka Organic Chem Ind Ltd 糖転移反応生成物の製造法
JPH02308798A (ja) * 1989-03-24 1990-12-21 Osaka Organic Chem Ind Ltd 糖転移反応生成物の製造法
JPH02268685A (ja) * 1989-04-07 1990-11-02 Tax Adm Agency 新規遺伝子、ベクター、それを用いた形質転換体及びその利用

Also Published As

Publication number Publication date
CA2100775A1 (en) 1992-08-07
DK0571475T3 (da) 1996-03-04
ATE130630T1 (de) 1995-12-15
NZ241560A (en) 1993-09-27
WO1992013945A1 (en) 1992-08-20
DE69206258T2 (de) 1996-03-28
JP3240002B2 (ja) 2001-12-17
AU1246792A (en) 1992-09-07
GR3018913T3 (en) 1996-05-31
EP0571475A1 (en) 1993-12-01
AU649789B2 (en) 1994-06-02
EP0571475B1 (en) 1995-11-22
US5474922A (en) 1995-12-12
DE69206258D1 (de) 1996-01-04
EP0498137A1 (en) 1992-08-12
JPH06505154A (ja) 1994-06-16

Similar Documents

Publication Publication Date Title
NO851599L (no) Injeksjonssproeyte, saerlig til bruk for tannleger
EP0332677A4 (en) Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
EP0337967A3 (en) Compositions inducing the binding between parts of living mineralized tissue
FI850744L (fi) Ny hjaertfoermak-peptid.
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
DK77490A (da) Substituerede arylurinstofderivater, deres fremstilling og anvendelse som soedemidler
ES2080486T3 (es) Sg(beta)-1,4-galactanasa y una secuencia de adn.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
ES2058479T3 (es) Compuestos peptidicos.
AR247919A1 (es) Endo-1, 4-beta-glucanasa y secuencia de adn
ES8800985A1 (es) Procedimiento de preparar proteinas.
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
DK93886A (da) Molekylaer kloning af delta-endotoksingenet af bacillus thuringiensisvar. israelensis
DK640188A (da) Peptid til rensning af faktor viii, fremstilling deraf samt praeparering af faktor viii
DK146789A (da) Polypeptider med vaekstfaktoraktivitet og nucleinsyresekvenser, der koder for polypeptiderne
IT8419497A0 (it) Procedimento di purificazione del caprolattame.
GR3003132T3 (en) Pharmaceutical compositions having healing activity
DK112785D0 (da) 3-cyclopropylmethyl-1,3,5-triazin-2,4-dioner
DK270185D0 (da) Injektionssproejte, isaer til engangsbrug

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571475

Country of ref document: ES